APEN Annual Cash & Cash Equivalents
$57.00 M
-$33.69 M-37.15%
31 December 2022
Summary:
As of February 5, 2025, APEN annual cash & cash equivalents is $57.00 million, with the most recent change of -$33.69 million (-37.15%) on December 31, 2022. During the last 3 years, it has risen by +$27.10 million (+90.61%).APEN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APEN Quarterly Cash And Cash Equivalents
$57.00 M
-$9.90 M-14.80%
31 December 2022
Summary:
As of February 5, 2025, APEN quarterly cash and cash equivalents is $57.00 million, with the most recent change of -$9.90 million (-14.80%) on December 31, 2022. Over the past year, it has dropped by -$33.69 million (-37.15%).APEN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APEN Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -37.1% | -37.1% |
3 y3 years | +90.6% | +90.6% |
5 y5 years | +86.8% | +86.8% |
APEN Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -37.1% | -37.1% |
Apollo Endosurgery Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $57.00 M(-37.1%) | $57.00 M(-14.8%) |
Sept 2022 | - | $66.91 M(-10.5%) |
June 2022 | - | $74.74 M(-8.6%) |
Mar 2022 | - | $81.73 M(-9.9%) |
Dec 2021 | $90.69 M(+150.3%) | $90.69 M(+231.6%) |
Sept 2021 | - | $27.35 M(-10.4%) |
June 2021 | - | $30.54 M(-3.7%) |
Mar 2021 | - | $31.71 M(-12.5%) |
Dec 2020 | $36.23 M(+21.2%) | $36.23 M(-3.2%) |
Sept 2020 | - | $37.43 M(+96.0%) |
June 2020 | - | $19.10 M(-17.7%) |
Mar 2020 | - | $23.21 M(-22.4%) |
Dec 2019 | $29.91 M(+24.6%) | $29.91 M(-14.5%) |
Sept 2019 | - | $34.97 M(+52.6%) |
June 2019 | - | $22.92 M(-23.5%) |
Mar 2019 | - | $29.97 M(+24.9%) |
Dec 2018 | $24.00 M(-21.4%) | $24.00 M(-15.6%) |
Sept 2018 | - | $28.44 M(-17.3%) |
June 2018 | - | $34.38 M(+53.9%) |
Mar 2018 | - | $22.34 M(-26.8%) |
Dec 2017 | $30.51 M(+59.7%) | $30.51 M(-11.7%) |
Sept 2017 | - | $34.55 M(+551.7%) |
June 2017 | - | $5.30 M(-36.1%) |
Mar 2017 | - | $8.30 M(-56.6%) |
Dec 2016 | $19.11 M(+115.0%) | $19.11 M(+474.9%) |
Sept 2016 | - | $3.32 M(-28.7%) |
June 2016 | - | $4.66 M(-33.6%) |
Mar 2016 | - | $7.02 M(-21.0%) |
Dec 2015 | $8.89 M(-48.6%) | $8.89 M(-23.1%) |
Sept 2015 | - | $11.55 M(-2.5%) |
June 2015 | - | $11.85 M(-6.5%) |
Mar 2015 | - | $12.67 M(-26.7%) |
Dec 2014 | $17.28 M(+45.8%) | $17.28 M(-15.7%) |
Sept 2014 | - | $20.51 M(+43.8%) |
June 2014 | - | $14.26 M(-11.5%) |
Mar 2014 | - | $16.11 M(+35.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | $11.85 M(-51.9%) | $11.85 M(-20.5%) |
Sept 2013 | - | $14.91 M(-14.8%) |
June 2013 | - | $17.51 M(-14.8%) |
Mar 2013 | - | $20.54 M(-16.6%) |
Dec 2012 | $24.62 M(+70.9%) | $24.62 M(+53.7%) |
Sept 2012 | - | $16.02 M(-12.2%) |
June 2012 | - | $18.24 M(+2.6%) |
Mar 2012 | - | $17.79 M(+23.4%) |
Dec 2011 | $14.41 M(+111.8%) | $14.41 M(-9.2%) |
Sept 2011 | - | $15.87 M(-14.9%) |
June 2011 | - | $18.65 M(-0.4%) |
Mar 2011 | - | $18.73 M(+175.3%) |
Dec 2010 | $6.80 M(+10.2%) | $6.80 M(+118.5%) |
Sept 2010 | - | $3.11 M(-36.2%) |
June 2010 | - | $4.88 M(-28.6%) |
Mar 2010 | - | $6.83 M(+10.7%) |
Dec 2009 | $6.17 M(-20.6%) | $6.17 M(-4.4%) |
Sept 2009 | - | $6.45 M(+18.2%) |
June 2009 | - | $5.46 M(-19.0%) |
Mar 2009 | - | $6.74 M(-13.3%) |
Dec 2008 | $7.78 M(+3.4%) | $7.78 M(+31.7%) |
Sept 2008 | - | $5.90 M(+211.8%) |
June 2008 | - | $1.89 M(-64.9%) |
Mar 2008 | - | $5.40 M(-28.2%) |
Dec 2007 | $7.52 M(+452.5%) | $7.52 M(-30.1%) |
Sept 2007 | - | $10.76 M(-25.3%) |
June 2007 | - | $14.40 M(+2051.9%) |
Mar 2007 | - | $669.10 K(-50.8%) |
Dec 2006 | $1.36 M(-73.8%) | $1.36 M(-52.4%) |
Sept 2006 | - | $2.86 M(-30.4%) |
June 2006 | - | $4.11 M(-21.0%) |
Mar 2006 | - | $5.20 M(+0.3%) |
Dec 2005 | $5.19 M | $5.19 M(>+9900.0%) |
Sept 2005 | - | $1500.00(-31.8%) |
June 2005 | - | $2200.00(+1000.0%) |
Mar 2005 | - | $200.00 |
FAQ
- What is Apollo Endosurgery annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Apollo Endosurgery?
- What is Apollo Endosurgery annual cash & cash equivalents year-on-year change?
- What is Apollo Endosurgery quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Apollo Endosurgery?
- What is Apollo Endosurgery quarterly cash and cash equivalents year-on-year change?
What is Apollo Endosurgery annual cash & cash equivalents?
The current annual cash & cash equivalents of APEN is $57.00 M
What is the all time high annual cash & cash equivalents for Apollo Endosurgery?
Apollo Endosurgery all-time high annual cash & cash equivalents is $90.69 M
What is Apollo Endosurgery annual cash & cash equivalents year-on-year change?
Over the past year, APEN annual cash & cash equivalents has changed by -$33.69 M (-37.15%)
What is Apollo Endosurgery quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of APEN is $57.00 M
What is the all time high quarterly cash and cash equivalents for Apollo Endosurgery?
Apollo Endosurgery all-time high quarterly cash and cash equivalents is $90.69 M
What is Apollo Endosurgery quarterly cash and cash equivalents year-on-year change?
Over the past year, APEN quarterly cash and cash equivalents has changed by -$33.69 M (-37.15%)